A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial
Open accessThe DOI matches its Crossref record; 106 of the 107 references it cites were found in a registry or an index.
Abstract
Background: Heavy menstrual bleeding (HMB) is a common problem, yet evidence to inform decisions about initial medical treatment is limited. Objectives: To assess the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system (LNG-IUS) (Mirena ® , Bayer) compared with usual medical treatment, with exploration of women’s perspectives on treatment. Design: A pragmatic, multicentre randomised trial with an economic evaluation and a longitudinal qualitative study. Setting: Women who presented in primary care. Participants: A total of 571 women with HMB. A purposeful sample of 27 women who were randomised or ineligible owing to treatment preference participated in semistructured face-to-face interviews around 2 and 12 months after commencing treatment. Interventions: LNG-IUS or usual medical treatment (tranexamic acid, mefenamic acid, combined oestrogen–progestogen or progesterone alone). Women could subsequently swap or cease their allocated treatment. Outcome measures: The primary outcome was the patient-reported score on the Menorrhagia Multi-Attribute Scale (MMAS) assessed over a 2-year period and then again at 5 years. Secondary outcomes included general quality of life (QoL), sexual activity, surgical intervention and safety. Data were analysed using iterative constant comparison. A state transition model-based cost–utility analysis was undertaken alongside the randomised trial. Quality-adjusted life-years (QALYs) were derived from the European Quality of Life-5 Dimensions (EQ-5D) and the Short Form questionnaire-6 Dimensions (SF-6D). The intention-to-treat analyses were reported as cost per QALY gained. Uncertainty was explored by conducting both deterministic and probabilistic sensitivity analyses. Results: The MMAS total scores improved significantly in both groups at all time points, but were significantly greater for the LNG-IUS than for usual treatment [mean difference over 2 years was 13.4 points, 95% confidence interval (CI) 9.9 to 16.9 points; p < 0.001]. However, this difference between groups was reduced and no longer significant by 5 years (mean difference in scores 3.9 points, 95% CI –0.6 to 8.3 points; p = 0.09). By 5 years, only 47% of women had a LNG-IUS in place and 15% were still taking usual medical treatment. Five-year surgery rates were low, at 20%, and were similar, irrespective of initial treatments. There were no significant differences in serious adverse events between groups. Using the EQ-5D, at 2 years, the relative cost-effectiveness of the LNG-IUS compared with usual medical treatment was £1600 per QALY, which by 5 years was reduced to £114 per QALY. Using the SF-6D, usual medical treatment dominates the LNG-IUS. The qualitative findings show that women’s experiences and expectations of medical treatments for HMB vary considerably and change over time. Women had high expectations of a prompt effect from medical treatments. Conclusions: The LNG-IUS, compared with usual medical therapies, resulted in greater improvement over 2 years in women’s assessments of the effect of HMB on their daily routine, including work, social and family life, and psychological and physical well-being. At 5 years, the differences were no longer significant. A similar low proportion of women required surgical intervention in both groups. The LNG-IUS is cost-effective in both the short and medium term, using the method generally recommended by the National Institute for Health and Care Excellence. Using the alternative measures to value QoL will have a considerable impact on cost-effectiveness decisions. It will be important to explore the clinical and health-care trajectories of the ECLIPSE (clinical effectiveness and cost-effectiveness of levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia) trial participants to 10 years, by which time half of the cohort will have reached menopause. Trial registration: Current Controlled Trials ISRCTN86566246. Funding: This project was funded by the NIHR Health Technology Assessment programme and will be published in full in Health Technology Assessment ; Vol. 19, No. 88. See the NIHR Journals Library website for further project information
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When this health benefit is valued in monetary terms at the UK Department of Health's current rate of £60 000 per QALY,24 this represents a ROI of 3.16 (£60 000−£13 000/£13 000).”
From Return on investment of public health interventions: a systematic review (2017) · cites this paper as [23]
In the citing paper
“It has been estimated that investing an additional £13 000 in the English National Health Service (NHS) can achieve health benefits of one additional quality-adjusted life year (QALY).23”
From Return on investment of public health interventions: a systematic review (2017) · cites this paper as [23]
In the citing paper
“many trials struggle with recruitment and often request extensions or become at risk of closure. 14 15”
From Role of feasibility and pilot studies in randomised controlled trials: a cross-sectional study (2018) · cites this paper as [14]
In the citing paper
“The mean cost of clinical trials funded by the UK National Institute for Health and Care Research was lower but still sizeable at about £1.3m, and also with considerable variation.104”
From SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials (2025) · cites this paper as [104]
Citations
Cites
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Grounded theory research: Procedures, canons, and evaluative criteria
Corbin, J. M., & Strauss, A. (1990) · Qualitative Sociology · doi:10.1007/bf00988593 · Cited by 11,133
Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003) · Medical Care · doi:10.1097/01.mlr.0000062554.74615.4c · Cited by 4,700 · cited 2×
“5 SD, which is the minimum clinically important difference identified in a systematic review of studies reporting such data for health-related QoL measures.(79) A 13.”
BackgroundScale Development: Theory and Applications.
Xie, Y., & DeVellis, R. F. (1992) · Contemporary Sociology · doi:10.2307/2075704 · Cited by 3,635 · cited 1×
“9, suggesting that the items are all measuring aspects of the same construct.(68) Evidence of the homogeneity of the MMAS was also provided by the item total correlations (the correlation between each item and the total score minus that item) which range between 0.”
BackgroundDecision Modelling For Health Economic Evaluation
Briggs, A., Claxton, K., & Sculpher, M. (2006) · doi:10.1093/oso/9780198526629.001.0001 · Cited by 3,153
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.220 · Cited by 2,294
The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS?
Garratt, A. M., Ruta, D. A., Abdalla, M. I., Buckingham, J. K., & Russell, I. T. (1993) · BMJ · doi:10.1136/bmj.306.6890.1440 · Cited by 1,141
Strategy for intention to treat analysis in randomised trials with missing outcome data
White, I. R., Horton, N. J., Carpenter, J., statistics, R. I. M. A. S., & Pocock, S. J. (2011) · BMJ · doi:10.1136/bmj.d40 · Cited by 849 · cited 1×
“A number of sensitivity analyses were performed on the primary outcome to test the robustness of the results.(77,78) Analyses were performed excluding data received subsequent to a crossover to the alternative treatment group and also once study treatment was ceased altogether.”
MethodLinear mixed models for longitudinal data
(2000) · Springer Series in Statistics · doi:10.1007/b98969 · Cited by 818
A comparison of the EQ‐5D and SF‐6D across seven patient groups
Brazier, J., Roberts, J., Tsuchiya, A., & Busschbach, J. (2004) · Health Economics · doi:10.1002/hec.866 · Cited by 797 · cited 1×
“However, at the inception of this trial in 2002, the use of SF-6D was in its infancy and still being developed.(101) It was included in the current study as a methodological component.”
Method
Research works printed but not linked: 12
- National Institute for Health and Care Excellence, 2007, Heavy Menstrual Bleeding: Guideline CG44
- Royal College of Obstetrics and Gynaecology (RCOG), 1998, The Initial Management of Menorrhagia – Evidence-Based Clinical Guidelines No. 1
- Joint Formulary Committee, 2011, British National Formulary
- Gheit, 2009, Bleeding patterns associated with progestin-only contraceptives: a prospective controlled trial comparing Mirena versus progestin only pill, Middle East Fertil Soc J, 14, 216
- Kari, 2005, Randomized, Open-Label, Multicenter Study Comparing the Efficacy and Safety of Mirena to a Three-Month Administration of Danazol Followed by a 3-Month Observation Period in Women Aged over 30 with Functional Menorrhagia
- Muenzen, 2009, A multicenter, randomized, open label, parallel group, active control study to evaluate the efficacy and safety of LNG IUS (Mirena) as compared to medroxyprogesterone acetate during 6 cycles of treatment in patients with idiopathic menorrhagia, BSP Report
- National Institute for Health and Care Excellence, 2013, Guide to the Methods of Technology Appraisal
- Cohen, 1977, Statistical Power Analysis for the Behavioural Sciences
- Shaw, 2007, Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia, Aust N Z J Obstet Gynaecol, 47, 335, 10.1111/j.1479-828X.2007.00747.x · DOI
- Belevantsev, Model of transition from anodization to microarc stage, Izv Sib Otd an Khim, 6, 73
- Curtis, 2012, Unit Costs of Health and Social Care 2011
- National Institute for Health and Care Excellence, 2008, Guide to the Methods of Technology Appraisal
Cited by
Items 101–200 of 395
Williamson, E. M., McConkey, C. C., Heine, P., Dosanjh, S., Williams, M. A., & Lamb, S. E. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013121 · Cited by 33
Economics of physical activity in low-income and middle- income countries: a systematic review
Ranasinghe, P. D., Pokhrel, S., & Anokye, N. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-037784 · Cited by 36
Blake, L., Duarte, R. V., & Cummins, C. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010507 · Cited by 32
Bruce, J., Williamson, E. M., Lait, C., Richmond, H., Betteley, L., Lall, R., Petrou, S., Rees, S., Withers, E. J., Lamb, S. E., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-019078 · Cited by 43
Jones, H., George, K., Scott, A., Buckley, J., Watson, P. M., Oxborough, D., Thijssen, D. H. J., Graves, L., Whyte, G. P., McGregor, G., et al. (2021) · BMJ Open Sport & Exercise Medicine · doi:10.1136/bmjsem-2021-001158 · Cited by 39
Collin, S. M., Wurie, F. B., Muzyamba, M. C., de Vries, G., Lönnroth, K., Migliori, G. B., Abubakar, I. I., Anderson, S. R., & Zenner, D. (2019) · European Respiratory Review · doi:10.1183/16000617.0107-2018 · Cited by 35
Management of venous thromboembolism in far-advanced cancer: current practice
Noble, S., Banerjee, S., & Pease, N. J. (2019) · BMJ Supportive & Palliative Care · doi:10.1136/bmjspcare-2019-001804 · Cited by 31
Mugwagwa, T., Abubakar, I., & White, P. J. (2021) · Thorax · doi:10.1136/thoraxjnl-2019-214004 · Cited by 31
Coe, A., Kaylor‐Hughes, C., Fletcher, S. L., Murray, E., & Gunn, J. M. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-052547 · Cited by 37
Pulmonary rehabilitation and severe exacerbations of COPD: solution or white elephant?
Man, W., Puhan, M., Harrison, S., Jordan, R., Quint, J., & Singh, S. (2015) · ERJ Open Research · doi:10.1183/23120541.00050-2015 · Cited by 36
Abbott, A. D., Schröder, K., Enthoven, P., Nilsén, P., & Öberg, B. E. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-019906 · Cited by 30
Feehan, M., Walsh, M. W., Duker, H. V., Godin, J., Munger, M. A., Fleming, R. P., Johnson, S. A., Morrison, M. A., DeAngelis, M. M., & Witt, D. M. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2018.05.025 · Cited by 31
Ochalek, J., Abbas, K., Claxton, K., Jit, M., & Lomas, J. R. S. (2020) · BMJ Global Health · doi:10.1136/bmjgh-2020-003006 · Cited by 37
Exploration of GP perspectives on deprescribing antidepressants: a qualitative study
Kelly, D., Graffi, J., Noonan, M., Green, P., Mcfarland, J. W., Hayes, P., & Glynn, L. G. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-046054 · Cited by 36
Costs, quality of life and cost-effectiveness of arthroscopic and open repair for rotator cuff tears
Murphy, J., Gray, A. M., Cooper, C., Cooper, D., Ramsay, C. R., & Carr, A. J. (2016) · The Bone & Joint Journal · doi:10.1302/0301-620x.98b12.bjj-2016-0121.r1 · Cited by 30
Bobos, P., MacDermid, J. C., Ziebart, C., Boutsikari, E. C., Lalone, E., Ferreira, L. M., & Grewal, R. S. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-041935 · Cited by 29
Munford, L. A., Sidaway, M., Blakemore, A., Sutton, M., & Bower, P. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-012374 · Cited by 32
Diabetes detection in women with gestational diabetes and polycystic ovarian syndrome
Hanna, F., Wu, P., Heald, A. H., & Fryer, A. A. (2023) · BMJ · doi:10.1136/bmj-2022-071675 · Cited by 35
Trends and key disparities of obesity among US adolescents: The NHANES from 2007 to 2020
Deng, Y., Yli-Piipari, S. R., Shahawy, O. E., & Tamura, K. (2024) · PLoS ONE · doi:10.1371/journal.pone.0290211 · Cited by 35
Smoking and Mental Illness: A Bibliometric Analysis of Research Output Over Time
Metse, A. P., Wiggers, J., Wye, P. M., Wolfenden, L., Prochaska, J. J., Stockings, E., Williams, J. M., Ansell, K., Fehily, C. M. C., & Bowman, J. (2016) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntw249 · Cited by 30
Knuchel-Takano, A., Hunt, D., Jaccard, A., Bhimjiyani, A. G., Brown, M., Retat, L., Brown, K., Hinde, S., Selvarajah, C., Bauld, L., et al. (2017) · Tobacco Control · doi:10.1136/tobaccocontrol-2017-053860 · Cited by 31
Weigel, S., Gerß, J., Hense, H., Krischke, M., Sommer, A., Czwoydzinski, J., Lenzen, H., Kerschke, L., Spieker, K., Dickmaenken, S., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-020475 · Cited by 25
Launonen, A. P., Fjalestad, T., Laitinen, M., Lähdeoja, T., Ekholm, C., Wagle, T. M., & Mattila, V. M. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024916 · Cited by 28
Hussain, A. R., Gul, M. A., & Khalid, M. U. (2019) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2019-000316 · Cited by 26
Audigé, L., Bucher, H. C., Aghlmandi, S., Stojanov, T., Schwappach, D. L. B., Hunziker, S., Candrian, C., Cunningham, G. J., Durchholz, H., Eid, K., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-045702 · Cited by 30
Zylbersztejn, A., Lewis, K. M., Nguyen, V. G., Matthews, J., Winterburn, I., Karwatowska, L., Barnes, S., Lilliman, M., Saxton, J., Stone, A., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-072531 · Cited by 32
Donkor, H. M., Grundt, J. H., Júlíusson, P. B., Eide, G. E., Hurum, J., Bjerknes, R., & Markestad, T. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014548 · Cited by 29
Greenwell, K., Sivyer, K., Vedhara, K., Yardley, L., Game, F. L., Chalder, T., Richards, G., Drake, N., Gray, K., Weinman, J. A., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-019865 · Cited by 28
Williamson, E. M., Ward, L., Vadher, K., Dutton, S., Parker, B., Petrou, S., Hutchinson, C. E., Gagen, R., Arden, N., Barker, K. L., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-022205 · Cited by 27
Supplemental oxygen and noninvasive ventilation
Owens, R. L., Derom, E., & Ambrosino, N. (2023) · European Respiratory Review · doi:10.1183/16000617.0159-2022 · Cited by 67
Holst, A., Björkelund, C., Metsini, A., Madsen, J.-H., Hange, D., Petersson, E., Eriksson, M. C. M., Kivi, M., Andersson, P.-Å., & Svensson, M. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-019716 · Cited by 27
Broadbent, D., Sampson, C., Wang, A., Howard, L., Williams, A. E., Howlin, S. U., Appelbe, D. E., Moitt, T., Cheyne, C. P., Mobayen‐Rahni, M., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025788 · Cited by 27
Brown, R., Welsh, P. I., & Logue, J. (2020) · Open Heart · doi:10.1136/openhrt-2020-001396 · Cited by 26
Understanding cardiac troponin part 1: avoiding troponinitis
Body, R. M., & Carlton, E. W. (2017) · Emergency Medicine Journal · doi:10.1136/emermed-2017-206812 · Cited by 23
Carrillo-Larco, R. M., Castillo‐Cara, M., Anza‐Ramirez, C., & Bernabé‐Ortiz, A. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001889 · Cited by 25
Therapeutic options for the management of abnormal uterine bleeding
MacGregor, B., Munro, M. G., & Lumsden, M. A. (2023) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14947 · Cited by 32
Hopewell, S., Keene, D. J., Schlüssel, M. M., Dritsaki, M., Dutton, S., Carr, A. J., Hamilton, W. T., Hansen, Z., Jaggi, A., Littlewood, C., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-018004 · Cited by 25
Hughes, S., Rapport, F., Watkins, A. J., Boisvert, I., McMahon, C. M., & Hutchings, H. A. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-028881 · Cited by 28
Bar-Zeev, Y., Bonevski, B., Bovill, M., Gruppetta, M., Oldmeadow, C., Palazzi, K., Atkins, L., Reath, J., & Gould, G. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016095 · Cited by 25
Mino, E., Geidl, W., Naber, I., Weißenfels, A., Klamroth, S., Gelius, P. C., Abu‐Omar, K., & Pfeifer, K. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-049549 · Cited by 26
Shannon, O. M., Lee, V. Y., Bundy, R., Gillings, R., Jennings, A., Stephan, B. C. M., Hornberger, M., Balanos, G. M., Paddick, S., Hanson, S., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-042823 · Cited by 23
Dispositivo Intrauterino na Atenção Primária a Saúde
Barrêto, D. D. S., Maia, D. S., Gonçalves, R. D., & Soares, R. D. S. (2021) · Revista Brasileira de Medicina de Família e Comunidade · doi:10.5712/rbmfc16(43)2821 · Cited by 22
Makovec, U. N., Goetzinger, C., Ribaut, J., Barnestein‐Fonseca, P., Haupenthal, F., Herdeiro, M. T., Grant, S., Jácome, C. I. O., Roque, F., Šmits, D., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-059674 · Cited by 22
Advancing preparedness for clinical research during infectious disease epidemics
Gobat, N., Amuasi, J., Yazdanpanah, Y., Sigfrid, L., Davies, H. T., Byrne, J.-P., Carson, G., Butler, C., Nichol, A., & Goossens, H. (2019) · ERJ Open Research · doi:10.1183/23120541.00227-2018 · Cited by 21
Free, C., McCarthy, O., Palmer, M. J., Knight, R., Edwards, P., French, R., Baraitser, P., Hickson, F. C. I., Wellings, K., Roberts, I., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-031635 · Cited by 21
Qian, Y., Walters, S. J., Jacques, R., & Flight, L. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-051673 · Cited by 27
Bateman, M., Saunders, B., Littlewood, C., & Hill, J. C. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-053841 · Cited by 26
Intensiveversusshort face-to-face smoking cessation interventions: a meta-analysis
Rasmussen, M., Lauridsen, S. V., Pedersen, B., Backer, V., & Tønnesen, H. (2022) · European Respiratory Review · doi:10.1183/16000617.0063-2022 · Cited by 23
Schmidtke, K. A., Evison, F., Grove, A., Kudrna, L., Tucker, O., Metcalfe, A. J., Bradbury, A. W., Bhangu, A. A., & Lilford, R. J. (2022) · BMJ Quality & Safety · doi:10.1136/bmjqs-2022-015077 · Cited by 26
Shahab, L., Dobbie, F., Hiscock, R., McNeill, A. D., & Bauld, L. (2016) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntw258 · Cited by 25
Webber, R. J., Sweet, R. M., & Webber, D. S. (2018) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2018.026377 · Cited by 21
Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance
Stagg, H. R., Bothamley, G. H., Davidson, J. A., Kunst, H., Lalor, M. K., Lipman, M. C. I., Loutet, M. G., Lozewicz, S., Mohiyuddin, T., Abbara, A., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.00982-2019 · Cited by 21
Tickell, A., Byng, R., Crane, C., Gradinger, F., Hayes, R. A., Robson, J., Cardy, J., Weaver, A. N., Morant, N. J., & Kuyken, W. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-033892 · Cited by 23
de Stegge, W. B. A., Schut, M. C., Abu–Hanna, A., van Baal, J. G., van Netten, J. J., & Bus, S. A. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002257 · Cited by 33
Emerging Therapies for COVID-19: The Value of Information From More Clinical Trials
Dijk, S. W., Krijkamp, E., Kunst, N., Gross, C. P., Wong, J. B., & Hunink, M. G. M. (2022) · Value in Health · doi:10.1016/j.jval.2022.03.016 · Cited by 22
Access systems in general practice: a systematic scoping review
Eccles, A., Bryce, C., Driessen, A., Pope, C. J., MacLellan, J., Gronlund, T. A., Nicholson, B. D., Ziébland, S., & Atherton, H. (2024) · British Journal of General Practice · doi:10.3399/bjgp.2023.0149 · Cited by 23
Clinical implications of the global multidrug-resistant tuberculosis epidemic
Kumar, K., & Abubakar, I. I. (2015) · Clinical Medicine · doi:10.7861/clinmedicine.15-6-s37 · Cited by 27
Morici, N., Farioli, L., Losappio, L. M., Colombo, G., Nichelatti, M., Preziosi, D., Micarelli, G., Oliva, F. G., Giannattasio, C., Klugmann, S., et al. (2016) · Open Heart · doi:10.1136/openhrt-2016-000472 · Cited by 20
Tempfer, C. M., Hartmann, F., Hilal, Z., & Rezniczek, G. A. (2017) · BMC Cancer · doi:10.1186/s12885-016-3004-8 · Cited by 20
Cost-effectiveness of mammography from a publicly funded health care system perspective
Mittmann, N., Stout, N. K., Tosteson, A. N. A., Trentham‐Dietz, A., Alagöz, O., & Yaffe, M. J. (2018) · CMAJ Open · doi:10.9778/cmajo.20170106 · Cited by 20
Embracing the science of value in health
Krahn, M. D., Bryan, S., Lee, M. Y. K., & Neumann, P. J. (2019) · Canadian Medical Association Journal · doi:10.1503/cmaj.181606 · Cited by 22
Diagnosis and management of pediatric tuberculosis in Canada
Kitai, I., Morris, S. K., Kordy, F. N., & Lam, R. E. (2017) · Canadian Medical Association Journal · doi:10.1503/cmaj.151212 · Cited by 20
Lunny, C., Ramasubbu, C., Gerrish, S., Liu, T. W. B., Salzwedel, D. M., Puil, L. J., Mintzes, B. J., & Wright, J. M. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-031442 · Cited by 21
Chappell, F. M., Crawford, F., Horne, M., Leese, G., Martin, A., Weller, D., Boulton, A. J. M., Abbott, C. A., Monteiro‐Soares, M., Veves, A., et al. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002150 · Cited by 25
Darabian, S., Wade, J. P., Kur, J., Wade, S. D., Sayre, E. C., & Badii, M. (2022) · The Journal of Rheumatology · doi:10.3899/jrheum.211281 · Cited by 19
Ishizawa, C., Hirota, Y., Iida, R., Kaku, T., Hirata, T., Fukui, Y., Omura, E., Akaeda, S., Hiraoka, T., Matsuo, M., et al. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-01077-9 · Cited by 19
“A study using MMAS demonstrated that LNG-IUS significantly improved the HMB-related impairment of daily life, including work, social, and family life, psychological well-being, and physical well-being compared with the conventional medical therapies including oral contraceptive pills and medroxyprogesterone acetate fo…”
MethodLongitudinal recovery following distal radial fractures managed with volar plate fixation
Stinton, S. B., Graham, P. L., Moloney, N. A., Maclachlan, L., Edgar, D. W., & Pappas, E. (2017) · The Bone & Joint Journal · doi:10.1302/0301-620x.99b12.bjj-2017-0348.r1 · Cited by 19
Janjua, A., Roberts, T. E., Okeahialam, N. A., & Clark, T. J. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-015823 · Cited by 19
Self-citationAchten, J., Sones, W. R., Dias, J. J., Hedley, H., Cook, J. A., Dritsaki, M., Png, M. E., Gray, A. M., Lamb, S. E., & Costa, M. L. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-028474 · Cited by 19
Mahida, R. Y., Chotalia, M., Alderman, J. E., Patel, C., Hayden, A., Desai, R., Beesley, E., Crowley, L., Soltan, M., Bangash, M. N., et al. (2020) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2020-000731 · Cited by 19
Lee, H., Wiggers, J., Kamper, S. J., Williams, A. J., O’Brien, K. M., Hodder, R. K., Wolfenden, L., Yoong, S. L., Campbell, E. M., Haskins, R., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014652 · Cited by 19
Does NICE apply the rule of rescue in its approach to highly specialised technologies?
Charlton, V. (2021) · Journal of Medical Ethics · doi:10.1136/medethics-2020-106759 · Cited by 18
Ride, J., Lorgelly, P. K., Tran, T. D., Wynter, K. H., Rowe, H. J., & Fisher, J. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012086 · Cited by 25
Marti, J., Bachhuber, M. A., Feingold, J. H., Meads, D. M., Richards, M. R., & Hennessy, S. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016229 · Cited by 21
Fuller, G. W., Keating, S., Goodacre, S. W., Herbert, E., Perkins, G. D., Rosser, A., Gunson, I. M., Miller, J., Ward, M., Bradburn, M. J., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-035915 · Cited by 18
Hermelijn, S. M., Kersten, C. M., Mullassery, D., Muthialu, N., Çobanoğlu, N., Gärtner, S., Bagolan, P., Burgos, C. M., Sgrò, A., Heyman, S. R. G., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-044544 · Cited by 17
Pathan, S. A., Mitra, B., Romero, L., & Cameron, P. A. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015002 · Cited by 17
Larsen, S. B., Grove, E. L., Neergaard‐Petersen, S., Würtz, M., Hvas, A., & Kristensen, S. D. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006050 · Cited by 17
Yan, L., Wang, S., Yuan, Y., & Zhang, J. (2019) · Evidence-Based Mental Health · doi:10.1136/ebmental-2019-300088 · Cited by 18
Balikova, I., Postelmans, L. D., Pasteels, B., Coquelet, P., Catherine, J., Efendic, A., Hosoda, Y., Miyake, M., Yamashiro, K., ANGEL study group members, et al. (2019) · BMJ Open Ophthalmology · doi:10.1136/bmjophth-2019-000273 · Cited by 19
Sivaprasad, S., Netuveli, G., Wittenberg, R., Khobragade, R. N., Sadanandan, R., Gopal, B. K., Premnazir, L., Conroy, D. M., Srinath, J., Ramakrishnan, R., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-040577 · Cited by 19
Asthma prescribing according to Arg16Gly beta-2 genotype: a randomised trial in adolescents
Ruffles, T., Jones, C. J., Palmer, C., Turner, S., Grigg, J., Tavendale, R., Hogarth, F., Rauchhaus, P., Pilvinyte, K., Hannah, R., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.04107-2020 · Cited by 17
Sivaprasad, S., Raman, R., Rajalakshmi, R., Mohan, V., Deepa, M., Das, T., Ramasamy, K., Prevost, A. T., Wittenberg, R., Netuveli, G., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-039657 · Cited by 16
Financial incentives for quitting smoking in pregnancy: Are they cost‐effective?
McMeekin, N., Sinclair, L., Robinson‐Smith, L., Mitchell, A. J., Bauld, L., Tappin, D. M., & Boyd, K. (2023) · Addiction · doi:10.1111/add.16176 · Cited by 19
Metcalfe, A. J., Mannion, E. G., Parsons, H. M., Brown, J., Parsons, N., Fox, J., Kearney, R. S., Lawrence, T., Bush, H., McGowan, K., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-036829 · Cited by 16
Depallens, M. A., Guimarães, J. M. D. M., & Filho, N. D. A. (2020) · Cadernos de Saúde Pública · doi:10.1590/0102-311x00231819 · Cited by 16
Taylor, A. H., Taylor, R. S., Ingram, W. M., Dean, S. G., Jolly, K. B., Mutrie, N., Lambert, J. D., Yardley, L., Streeter, A., Greaves, C., et al. (2020) · British Journal of Sports Medicine · doi:10.1136/bjsports-2020-103121 · Cited by 25
Proportionate methods for evaluating a simple digital mental health tool
Davies, E. B., Craven, M. P., Martin, J. L., & Simons, L. (2017) · Evidence Based Mental Health · doi:10.1136/eb-2017-102755 · Cited by 15
Vilstrup, E., Graversen, D. S., Huibers, L., Christensen, M. B., & Pedersen, A. F. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-028434 · Cited by 15
Jurek, L., Occelli, P., Denis, A., Amestoy, A., Maffre, T., Dauchez, T., Orêve, M.-J., Baghdadli, A., Schroder, C. M., Jay, A., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-044669 · Cited by 20
Adams, J. M., Pell, D., Penney, T. L., Hammond, D. G., Vanderlee, L., & White, M. J. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-051677 · Cited by 15
Meza, N., Rojas, V., Liquitay, C. M. E., Pérez, I., Johnson, F. A., Claudia Amarales, O., Irarrázaval, M., Madrid, E., & Franco, J. V. A. (2022) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2021-111811 · Cited by 22
Antithrombotic dilemmas in stroke medicine: new data, unsolved challenges
Best, J. G., Cardus, B., Klijn, C. J. M., Lip, G. Y. H., Seiffge, D. J., Smith, E. E., & Werring, D. J. (2022) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-325249 · Cited by 22
Chen, S., Liu, J., Peng, S., & Zheng, Y. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.948709 · Cited by 24
“Gupta 2015 (20) (n = 571; vs. usual medical treatment) measured MBL using MMAS at 2 and 5 years and reported that the average MMAS score was greater in the LNG-IUS group than in the medical treatments group (MD = 13.4; 95% CI = 9.9–16.9; p < 0.001) at 2 years; however, no clear difference was…”
MethodInfluentialNorman, G., Mason, T., Dumville, J. C., Bower, P., Wilson, P. M., & Cullum, N. A. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-064345 · Cited by 21
Whitaker, L. H. R., Middleton, L. J., DANIELS, J. P., Williams, A. R. W., Priest, L., Odedra, S., Cheed, V., Stubbs, C., Clark, T. J., Lumsden, M.-A., et al. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.101995 · Cited by 23
Self-citationMacDonald, C., Bennekou, M., Midtgaard, J., Langberg, H., & Lieberman, D. E. (2024) · British Journal of Sports Medicine · doi:10.1136/bjsports-2024-108396 · Cited by 17
Cambon, L., Bergman, P., Faou, A.-L. L., Vincent, I., Maître, B. L., Pasquereau, A., Arwidson, P., Thomas, D., & Alla, F. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013604 · Cited by 17
McCormick, S. A., McDonald, K. R., Vatter, S., Orgeta, V., Poliakoff, E., Smith, S. J., Silverdale, M., Fu, B., & Leroi, I. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016801 · Cited by 16
Implementation of research evidence in orthopaedics: a tale of three trials
Reeves, K., Chan, S., Marsh, A., Gallier, S., Wigley, C. H., Khunti, K., & Lilford, R. J. (2019) · BMJ Quality & Safety · doi:10.1136/bmjqs-2019-010056 · Cited by 16
Metadata
- Authors
- Gupta, J. K., Daniels, J. P., Middleton, L. J., Pattison, H. M., Prileszky, G., Roberts, T. E., Sanghera, S., Barton, P., Gray, R., Kai, J., & on behalf of the ECLIPSE Collaborative Group
- Affiliations
- Birmingham Women's Hospital (GB)
- University of Birmingham (GB)
- Aston University (GB)
- University of Nottingham (GB)
- University of Oxford (GB)
- Corresponding author
- Daniels, Jane P
- ORCID
- Venue
- Health Technology Assessment
- Published
- 2015-10
- Volume
- 19
- Issue
- 88
- Pages
- 1-118
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- PMC
- PMC4781345
- OpenAlex
- W2152498789
- Cited by
- 399
- References
- 107
- Citations by year
- 2026: 13 · 2025: 26 · 2024: 25 · 2023: 28 · 2022: 32 · 2021: 53 · 2020: 50 · 2019: 44 · 2018: 48 · 2017: 49 · 2016: 28 · 2015: 3
- FWCI
- 45.25
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Health Technology Assessment (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Repository@Nottingham (University of Nottingham) (publishedVersion, other-oa)
- Explore Bristol Research (publishedVersion)
- Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Nottingham ePrints (University of Nottingham) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Bristol Research (University of Bristol) (submittedVersion)
- Funders
- Health Technology Assessment programme (02/06/02)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- levonorgestrel-releasing intrauterine system, menorrhagia, primary care, cost-effectiveness, quality of life, patient-reported outcomes, tranexamic acid, mefenamic acid
- MeSH terms
- Antifibrinolytic Agents, Contraceptive Agents, Female, Cost-Benefit Analysis, Female, Humans, Intrauterine Devices, Medicated, Menorrhagia, Primary Health Care, Surveys and Questionnaires, Technology Assessment, Biomedical, Tranexamic Acid, Treatment Outcome, Levonorgestrel, Quality-Adjusted Life Years
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.